HomeCompareDVYE vs NOBL

DVYE vs NOBL: Dividend Comparison 2026

DVYE yields 5.12% · NOBL yields 2.17%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DVYE wins by $5.1K in total portfolio value
10 years
DVYE
DVYE
● Live price
5.12%
Share price
$34.38
Annual div
$1.76
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$709.71
Full DVYE calculator →
NOBL
NOBL
● Live price
2.17%
Share price
$104.67
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.9K
Annual income
$249.78
Full NOBL calculator →

Portfolio growth — DVYE vs NOBL

📍 DVYE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDVYENOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DVYE + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DVYE pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DVYE
Annual income on $10K today (after 15% tax)
$434.92/yr
After 10yr DRIP, annual income (after tax)
$603.25/yr
NOBL
Annual income on $10K today (after 15% tax)
$184.52/yr
After 10yr DRIP, annual income (after tax)
$212.31/yr
At 15% tax rate, DVYE beats the other by $390.94/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DVYE + NOBL for your $10,000?

DVYE: 50%NOBL: 50%
100% NOBL50/50100% DVYE
Portfolio after 10yr
$25.4K
Annual income
$479.75/yr
Blended yield
1.89%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DVYE buys
0
NOBL buys
0
No recent congressional trades found for DVYE or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDVYENOBL
Forward yield5.12%2.17%
Annual dividend / share$1.76$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$28.0K$22.9K
Annual income after 10y$709.71$249.78
Total dividends collected$6.1K$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: DVYE vs NOBL ($10,000, DRIP)

YearDVYE PortfolioDVYE Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$11,212$511.68$10,917$217.08+$295.00DVYE
2$12,533$536.14$11,903$221.48+$630.00DVYE
3$13,970$560.10$12,962$225.68+$1.0KDVYE
4$15,531$583.50$14,099$229.68+$1.4KDVYE
5$17,225$606.28$15,319$233.49+$1.9KDVYE
6$19,059$628.39$16,628$237.10+$2.4KDVYE
7$21,043$649.82$18,033$240.53+$3.0KDVYE
8$23,187$670.53$19,539$243.78+$3.6KDVYE
9$25,500$690.49$21,154$246.86+$4.3KDVYE
10$27,995$709.71$22,884$249.78+$5.1KDVYE

DVYE vs NOBL: Complete Analysis 2026

DVYEStock

The iShares Emerging Markets Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying equities in emerging markets.

Full DVYE Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this DVYE vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DVYE vs SCHDDVYE vs JEPIDVYE vs ODVYE vs KODVYE vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.